跳至主要内容
临床试验/NCT06280040
NCT06280040招募中不适用

Longitudinal Follow-Up of Retinopathy and Opticopathy After Treatment With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年11月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
20
试验地点
1
主要终点
Incidence and Severity of Retinopathy

研究概览

简要总结

The purpose of this study is to evaluate the incidence and severity of retinopathy and opticopathy one year after treatment with hypofractionated stereotactic photon radiotherapy due to uveal melanoma. Patients will be imaged before radiation, as well as 3, 6, 9 and 12 months after radiation using sonography funds photography, optical coherence tomography angiography, oximeter and microperimetry.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with newly diagnosed uveal melanoma, who will be treated with hypofractionated stereotactic photon radiotherapy as part of clinical routine.

排除标准

  • unwillingness to participate in the study
  • severe media opacity

结局指标

主要结局

Incidence and Severity of Retinopathy

时间窗: 1 year

Incidence and severity of retinopathy will be evaluated as non-perfusion areas on optical coherence tomography angiography

次要结局

  • Functional Outcome(1 year)
  • Incidence and Severity of Retinopathy and Opticopathy in oximeter(1 year)
  • Incidence and Severity of Opticopathy(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reinhard Told

MD, PHD

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验